Here's Why Adaptimmune Therapeutics Is Rocketing Higher Today @themotleyfool #stocks $ADAP https://t.co/OZFevdkKsN @Gamma_Monkey #stocks #stockmarket #investing #trading #stockmarketnews #news #stocktrading #business #wallstreet #alpha #alphanews #Canada #Questrade